Is the UK’s life sciences regulator, the MHRA, creating the right conditions to encourage businesses investing in artificial intelligence products? Peter Rudd-Clarke, a Partner in Osborne Clarke’s life sciences and healthcare team, Tamara Quinn, a Director in Osborne Clarke’s AI, data and IP knowledge team,...
